Publications by authors named "Eva Goetz"

Claim this Profile
T
Translatome of dorsal striatum parvalbumin interneurons revisited: insights across diverse experimental paradigms.
Claire Naon, Laia Castell, Steeve Thirard, Maria Moreno, Stéphanie Rialle, Eva Goetz

Front Cell Neurosci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic Characterization of a Comprehensive Set of MAPK1/ERK2 Missense Mutants.
Lisa Brenan, Aleksandr Andreev, Ofir Cohen, Sasha Pantel, Atanas Kamburov, Eva M Goetz

Cell Rep· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Resistance to Mitogen-Activated Protein Kinase Pathway Inhibition in BRAF-Mutant Melanoma.
Eva M Goetz, Levi A Garraway

Am Soc Clin Oncol Educ Book· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.
Eliezer M Van Allen, Vivian W Y Lui, Ann Marie Egloff, Eva M Goetz, Hua Li

JAMA Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors.
Eva M Goetz, Mahmoud Ghandi, Daniel J Treacy, Nikhil Wagle, Levi A Garraway

Cancer Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma.
Eliezer M Van Allen, Nikhil Wagle, Antje Sucker, Daniel J Treacy, Cory M Johannessen, Eva M Goetz

Cancer Discov· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition.
Nikhil Wagle, Eliezer M Van Allen, Daniel J Treacy, Dennie T Frederick, Zachary A Cooper, Eva M Goetz

Cancer Discov· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.
Dalia Ercan, Chunxiao Xu, Masahiko Yanagita, Calixte S Monast, Christine A Pratilas, Eva M Goetz

Cancer Discov· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis